Uldall, 1987 - Google Patents
Quality assurance within clinical chemistry—a brief review emphasizing 'good laboratory practice'Uldall, 1987
- Document ID
- 830797807840186281
- Author
- Uldall A
- Publication year
- Publication venue
- Scandinavian Journal of Clinical and Laboratory Investigation
External Links
Snippet
Goals for analytical quality within clinical chemistry should be recognized in order to select proper analytical methods including internal quality control systems, which in principle could guarantee the analytical quality. However, such an ideal scheme is only successful if the …
- 238000000275 quality assurance 0 title abstract description 17
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Simundic et al. | Managing hemolyzed samples in clinical laboratories | |
| Jensen et al. | Method comparison in the clinical laboratory | |
| Zhou et al. | Practical application of Six Sigma management in analytical biochemistry processes in clinical settings | |
| Oosterhuis et al. | The use of error and uncertainty methods in the medical laboratory | |
| Jennings et al. | Recommended principles and practices for validating clinical molecular pathology tests | |
| Lin et al. | Statistical methods in assessing agreement: Models, issues, and tools | |
| Westgard | Managing quality vs. measuring uncertainty in the medical laboratory. | |
| Rifai | Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8 e; South Asia edition; E-book | |
| Shahangian | Proficiency testing in laboratory medicine | |
| Vermeersch et al. | How to meet ISO15189: 2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE | |
| Peng et al. | Practical application of Westgard Sigma rules with run size in analytical biochemistry processes in clinical settings | |
| Padoan et al. | An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes | |
| Gomez-Rioja et al. | Recommendation for the design of stability studies on clinical specimens | |
| Hainrichson et al. | A point-of-need platform for rapid measurement of a host-protein score that differentiates bacterial from viral infection: analytical evaluation | |
| Selliah et al. | Flow cytometry method validation protocols | |
| Bietenbeck et al. | External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact | |
| Flatland et al. | Analytical quality goals—a review | |
| Omana-Zapata et al. | Accurate and reproducible enumeration of T-, B-, and NK lymphocytes using the BD FACSLyric 10-color system: A multisite clinical evaluation | |
| Walther et al. | Accuracy of a point-of-care blood lactate measurement device in a prehospital setting | |
| Pereira | Uncertainty of measurement in medical laboratories | |
| Crowther | Validation of diagnostic tests for infectious diseases | |
| Ahmed El‐Neanaey et al. | Evaluation of Sigma metric approach for monitoring the performance of automated analyzers in hematology unit of Alexandria Main University Hospital | |
| Brooks | Performance-driven quality control | |
| Rifai | Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics-E-Book: Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics-E-Book | |
| Prence | A practical guide for the validation of genetic tests |